A 32-week fetus with tachycardia and bradycardia, diagnosed with torsades de pointes, atrioventricular block, and sinus bradycardia due to a de novo mutation was successfully managed by a cardio-obstetrical team. Maternal/fetal pharmacogenomic testing resulted in appropriate drug dosing without toxicity and delivery of a term infant in sinus rhythm.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10715977 | PMC |
http://dx.doi.org/10.1016/j.jaccas.2023.102110 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!